Paraoxonase gene polymorphism and the risk for Alzheimer's disease in the polish population

Dement Geriatr Cogn Disord. 2011;31(6):417-23. doi: 10.1159/000329571. Epub 2011 Jul 13.

Abstract

Background: The relationship between different paraoxonase (PON) gene polymorphisms and the risk of Alzheimer's disease (AD) was studied several times and the results were controversial.

Methods: We investigated the association of 4 single-nucleotide polymorphisms (SNPs) of the PON1 (M55L; Q192R; -161C/T) and the PON2 (C311S) genes that were shown to affect the risk of sporadic AD. We studied 360 Caucasian cases with late-onset AD and 354 nondemented controls.

Results: No significant differences were observed between the studied PON SNPs and AD risk. The results did not change after stratification of the apolipoprotein E status. Meta-analyses of studies in Caucasians assessing the associations between the PON1 M55L, -161C/T and Q192R SNPs and the risk of AD were performed, and no associations were found.

Conclusion: Our results suggest that the studied PON1 and PON2 polymorphisms are not associated with late-onset AD.

MeSH terms

  • Age Factors
  • Age of Onset
  • Aged
  • Alleles
  • Alzheimer Disease / epidemiology*
  • Alzheimer Disease / genetics*
  • Apolipoproteins E / genetics
  • Aryldialkylphosphatase / genetics*
  • DNA / genetics
  • Female
  • Gene Frequency
  • Genotype
  • Haplotypes
  • Humans
  • Linkage Disequilibrium
  • Male
  • Poland / epidemiology
  • Polymorphism, Genetic / genetics*
  • Polymorphism, Single Nucleotide
  • Population
  • Real-Time Polymerase Chain Reaction
  • Regression Analysis
  • Risk Factors
  • Sex Factors

Substances

  • Apolipoproteins E
  • DNA
  • Aryldialkylphosphatase